Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MGN1703 in Chronic HIV-1 Infection
NCT02443935Phase 2Completed
- Sponsor
- Aarhus University
- Start
- Apr 2015
- Primary completion
- Jun 2017
- Modality
- Antisense DNA, Prophylactic Vaccines, Small Interfering RNA (siRNA)
- Countries
- 1
01
Overview
A Phase 2 trial of lefitolimod in human immunodeficiency virus type 1 infection (HIV-1), sponsored by Aarhus University. Started Apr 2015; status: completed.
02
Drugs
lefitolimod
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT02443935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02443935.